Pharmaceutical formulation
US6946150B2 · kind B2 · utility
62Cited by
2References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 14, 2002 |
| Grant date | Sep 20, 2005 |
| Priority date | — |
| Expiry date | Aug 16, 2022 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB65B31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.